| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5946951 | Atherosclerosis | 2013 | 7 Pages |
Abstract
Simvastatin 40Â mg, simvastatin/ezetimibe 10/10Â mg and rosuvastatin 10Â mg significantly reduced 8-epiPGF2a, oxLDL and Lp-PLA2 activity and mass to a similar extent.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Elisavet Moutzouri, Evangelos N. Liberopoulos, Constantinos C. Tellis, Haralambos J. Milionis, Alexandros D. Tselepis, Moses S. Elisaf,